Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study
European Journal of Neurology · 2023-04 · 30 (4) · 1109-1117
DOI: 10.1111/ene.15645 ↗At a glance
Übersichtsarbeit in European Journal of Neurology, published online on 2022-12-08. Written by Idaira Rodríguez-Santana and 17 co-authors. Institution: HCD Economics, Cheshire, UK. Major MEDLINE topics: Huntington Disease. Cited 31 times so far (Crossref); 15 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Roche.
Abstract (original language)
Background and purpose The prevalence of Huntington disease (HD) has increased over time; however, there is a lack of up‐to‐date evidence documenting the economic burden of HD by disease stage. This study provides an estimate of the annual direct medical, nonmedical, and indirect costs associated with HD from participants in the Huntington's Disease Burden of Illness (HDBOI) study in five European countries and the USA.
Methods
The HDBOI is a retrospective, cross‐sectional study. Data collection was conducted between September 2020 and May 2021. Participants were recruited by their HD‐treating physicians and categorized as early stage (ES), mid stage (MS), or advanced stage (AS) HD. Data were collected via three questionnaires: a case report form, completed by physicians who collected health care resource use associated with HD to compute direct medical cost, and optional patient and caregiver questionnaires, which included information used to compute nondirect medical and indirect costs. Country‐specific unit cost sources were used.
Results
HDBOI cost estimates were €12,663 ( n = 2094) for direct medical costs, €2984 ( n = 359) for nondirect medical costs, and €47,576 ( n = 436) for indirect costs. Costs are higher in patients who are at later stages of disease; for example, direct medical costs estimates were €9220 ( n = 846), €11,885 ( n = 701), and €18,985 ( n = 547) for ES, MS, and AS, respectively. Similar trends were observed for nondirect and indirect costs. Costs show large variations between patients and countries.
Conclusions
Cost estimates from the HDBOI study show that people with HD and their caregivers bear a large economic burden that increases as disease progresses.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- HCD Economics, Cheshire, UK.
- Ottawa Hospital Research Institute, Ontario, Ottawa, Canada.
- Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Casa Sollievo della Sofferenza Research Hospital, San Giovanni Rotondo, Italy.
- European Huntington Association, Kristiansand, Norway.
- Manchester Centre for Genomic Medicine, Manchester, UK.
- Lega Italiana Ricerca Huntington, Rome, Italy.
ORCID profiles: Idaira Rodríguez-Santana
Funding
- Roche
Cite
APA
Rodríguez-Santana, I., Mestre, T., Squitieri, F., Willock, R., Arnesen, A., Clarke, A., D'Alessio, B., Fisher, A., Fuller, R., Hamilton, J. L., Hubberstey, H., Stanley, C., Vetter, L., Winkelmann, M., Doherty, M., Wu, Y., Finnegan, A., & Frank, S. (2023). Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study. European Journal of Neurology, 30(4), 1109-1117. https://doi.org/10.1111/ene.15645
Vancouver
Rodríguez-Santana I, Mestre T, Squitieri F, Willock R, Arnesen A, Clarke A, et al. Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study. European Journal of Neurology. 2023;30(4):1109-1117. doi:10.1111/ene.15645
BibTeX
@article{RodrguezSantana2023,
author = {Rodríguez-Santana, Idaira and Mestre, Tiago and Squitieri, Ferdinando and Willock, Rosa and Arnesen, Astri and Clarke, Alison and D'Alessio, Barbara and Fisher, Alex and Fuller, Rebecca and Hamilton, Jamie L and Hubberstey, Hayley and Stanley, Cath and Vetter, Louise and Winkelmann, Michaela and Doherty, Maria and Wu, Yunchou and Finnegan, Alan and Frank, Samuel},
title = {Economic burden of Huntington disease in Europe and the USA: Results from the Huntington's Disease Burden of Illness study},
journal = {European Journal of Neurology},
year = {2023},
volume = {30},
number = {4},
pages = {1109--1117},
doi = {10.1111/ene.15645}
}
EUVIMED